Sprint Bioscience AB (publ) (STO:SPRINT)
1.885
-0.010 (-0.53%)
At close: Mar 6, 2026
34.84% (1Y)
| Market Cap | 198.90M |
| Revenue (ttm) | 167.17M |
| Net Income (ttm) | 91.74M |
| Shares Out | 105.52M |
| EPS (ttm) | 0.98 |
| PE Ratio | 1.92 |
| Forward PE | 6.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 378,030 |
| Average Volume | 1,240,179 |
| Open | 1.900 |
| Previous Close | 1.895 |
| Day's Range | 1.815 - 1.910 |
| 52-Week Range | 0.360 - 2.350 |
| Beta | -0.62 |
| RSI | 48.51 |
| Earnings Date | Feb 12, 2026 |